Read more

November 11, 2019
1 min read
Save

PRP improves hair density in women, top five stories in dermatology

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Matthew Lin, MD
Matthew J. Lin

In the most popular Healio Dermatology story last week, mean hair density and hair caliber improved in a group of 30 women with androgenetic alopecia after platelet-rich plasma injections.

“Platelet-rich plasma is obviously a very hot topic at the moment, but most of the studies have been done in men, so we thought we’d contribute to the literature by looking at women,” Matthew J. Lin, MD, a dermatologist at Icahn School of Medicine at Mount Sinai, said during a presentation at the American Society for Dermatologic Surgery annual meeting.

Continue reading for the top five headlines.

 

PRP improves hair density, caliber in women with androgenetic alopecia

Platelet-rich plasma significantly improved hair density and caliber among women with androgenetic alopecia. Read more.

 

Experts optimize the total-body skin exam

Researchers developed a standardized total-body skin examination procedure using video recordings of dermatology faculty members and residents conducting regular total-body skin examinations. Read more.

 

iPLEDGE program reform called for to reduce administrative burden

Researchers, along with the American Academy of Dermatology, have organized an iPLEDGE Workgroup to advocate for its reform with the goal of reducing administrative burden. Read more.

 

Propranolol is gold standard in infantile hemangiomas

The common historical approach of “wait and see” for infantile hemangiomas can lead to bad outcomes, according to Lawrence A. Schachner, MD, a dermatologist and pediatrician. Read more.

 

FDA accepts new drug application for acne cream

The FDA has accepted for review the new drug application for clascoterone cream 1% and has set Aug. 27, 2020, as the Prescription Drug User Fee Act action date. Read more.